PHYTOMEDICAL ENTERS INTO EXPANDED COLLABORATIVE AGREEMENT FOR TYPE-2 DIABETES COMPOUND

PhytoMedical Technologies, Inc. today announced that it recently has extended the term and scope of its three-way Cooperative Research and Development Agreement (CRADA) with Iowa State University (ISU) and the USDA's Agricultural Research Service (ARS) so as to allow the Company to accelerate its research plans for the development of a new compound for the treatment of type-2 diabetes. INS News (http://feed.insnews.org/v-cgi/feeds.cgi?feedid=150&story_id=1701819)